Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Shattuck Labs, Inc. Chief Medical Officer Arundathy N. Pandite reported an open-market sale of 30,000 shares of common stock at a weighted average price of $7.01 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026.
Following this sale, Pandite continues to hold 136,219 shares of Shattuck Labs common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 30,000 shares ($210,300)
Net Sell
1 txn
Insider
Pandite Arundathy N.
Role
Chief Medical Officer
Sold
30,000 shs ($210K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,000 | $7.01 | $210K |
Holdings After Transaction:
Common Stock — 136,219 shares (Direct, null)
Footnotes (1)
- Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.62 to $7.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Shares sold: 30,000 shares
Weighted average sale price: $7.01 per share
Post-transaction holdings: 136,219 shares
+2 more
5 metrics
Shares sold
30,000 shares
Open-market sale on June 30, 2026
Weighted average sale price
$7.01 per share
Common stock sale
Post-transaction holdings
136,219 shares
Shares beneficially owned after sale
Sale price range
$6.62–$7.40 per share
Multiple transaction prices within range
Trading plan adoption date
February 2, 2026
Rule 10b5-1 trading plan
Key Terms
Rule 10b5-1 trading plan, weighted average price, open-market sale, Form 4
4 terms
Rule 10b5-1 trading plan regulatory
"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
